Our therapies
The first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults.
LENZ Therapeutics is committed to delivering scientifically innovative solutions to the eye care space.
We are eager to continue bringing products to market that are in line with our purpose: to free people to forget about their vision.
Phase 1
Phase 2
Phase 3
US FDA Registration
FDA Approval
Phase 1
Phase 2
Phase 3
US FDA Registration
FDA Approval
VIZZ™ - 1.44% Aceclidine
Presbyopia
Daily Eye Drop Treatment
Join our mission
At LENZ Therapeutics, we rise to the occasion with energy and courage to deliver for patients. As a part of our team, you’ll share that innate sense of responsibility to improve the greater good, using your expertise and passion to meaningfully improve lives—because you know you can.